Reconfiguring Policy and Clinical Practice
How Databases Have Transformed the Regulation of Pharmaceutical Care
Bibliographic Data
| ID | 5338260 |
|---|---|
| Authors | Maartje G H Niezen (Erasmus University Rotterdam), Maartje Niezen (Erasmus University Rotterdam, corresponding author), Roland Bal (0000-0001-7202-5053, Erasmus University Rotterdam), Antoinette De Bont (0000-0002-0745-4537, Erasmus University Rotterdam) |
| Year | 2013 |
| Volume | 38 |
| Issue | 1 |
| Pages | 44-66 |
| Publication date | 2013-01-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Science Technology & Human Values (JOURNAL) |
| Journal identifiers | ISSN: 0162-2439 • E-ISSN: 1552-8251 |
| Publisher | SAGE Publications Inc (PUBLISHER) |
| DOI | 10.1177/0162243911435277 |
| OpenAlex | W2005995230 |
| Language | EN |
| Citations received | 1 |
| References cited | 20 |
This article's aim is to understand if and how the efforts to accumulate and organize clinical data transformed the regulation of pharmaceutical care. The authors analyze how the employment of databases by collectives of physicians and researchers shape both clinical and policy practice-and thereby reshape the relation between clinical work and policy. Since the late 1990s, Dutch government has supported the development of clinical databases for specific expensive medicines to gain oversight about actual medicine use. To be able to produce evidence for appropriate medicine use, the collectives set regulations in clinical practice. These internal regulations provide a framework for establishing "appropriate medicine use", steering reimbursement decisions. However, internal regulation and policy rules differ in how quickly they can change. While the employment of databases in clinical practices results in a constant adjustment of the protocols, policy makers require the databases to provide for static moments of "proven appropriate medicine use" in order to account for and define a fixed and closed formulary. Subsequently, the employment of the databases did not deliver on the promise of oversight and control due to different clinical and policy requirements. Nevertheless, the databases did stimulate appropriate medicine use and reimbursement in clinical practice
Business · Clinical Practice · Database · Economics · Formulary · Health care · Management · Political science · Reimbursement · Computer Science · Engineering · Health Systems, Economic Evaluations, Quality of Life · Healthcare cost, quality, practices · Law · Medicine · Nursing · Pharmaceutical industry and healthcare · Finance
Trust in Numbers
Cancer Clinical Trials
From brainbank to database
Quantification and the Accounting Ideal in Science
Voxels in the Brain
Postscript to the Special Issue
Biomedical Conventions and Regulatory Objectivity
Databases as Scientific Instruments and Their Role in the Ordering of Scientific Work
Staging and Weighting Evidence in Biomedicine
Pragmatic Objectivity and the Standardization of Engineered Tissues
Regulatory Objectivity in Action
The health care state in the information age
Regulatory objectivity and the generation and management of evidence in medicine
Policy analysis in an information-rich environment
A Sociology of Technology Governance for the Information Age
Who's minding the data? Data Monitoring Committees in clinical cancer trials
Adaptive regulation or governmentality
| Unique citing works | 1 |
|---|---|
| Citations per year | 0,11 |
| Citation span | 2017 - 2017 (1) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 1 |